HealthIndia Panel Backs Eli Lilly's Mounjaro, Weight Loss Drug Set to Enter Indian Market India's expert panel recommends the approval of Eli Lilly's weight loss drug, Mounjaro, pending the completion of the Phase 4 trial and submission of manufacturing data.by John Lopez
HealthYogurt Gets Nod from FDA: Limited Evidence Suggests Reduction in Type 2 Diabetes Riskby Quincy Jon
HealthGlobal Health Crisis: Over 1 Billion People Worldwide Afflicted by Obesity, Including 159 Million Kidsby Quincy Jon
HealthDoes Ozempic and Wegovy Increase the Risk of Suicidal Thoughts? New Study Reveals the Answerby Jace Dela Cruz
HealthEli Lilly's Weight-Loss Drug Users Regain Over 20 Pounds After Discontinuation, Study Revealsby Quincy Jon
TechFatphobic Tweets? Study Reveals Majority of Obesity-Related Twitter Posts Are Negativeby Jace Dela Cruz
HealthObesity Gene: Researchers Find the Reason for One's Overeating, Links to Insulin Resistance, and MOREby Isaiah Richard